Skip to content

Neuromuscular Versus Resistance Training on Functional Capacity in Patients With Heart Failure.

Comparative Effects Between Neuromuscular Versus Resistance Training on Functional Capacity, Cardiorespiratory Fitness, and Lower Limb Performance in Patients With Heart Failure.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07519473
Enrollment
40
Registered
2026-04-09
Start date
2026-04-01
Completion date
2026-07-29
Last updated
2026-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Neuromuscular Training ,Resistance Training ,Cardiac Rehabilitation

Brief summary

This randomized controlled trial will compare the effects of neuromuscular training and resistance training on functional capacity, cardiorespiratory fitness, and lower limb performance in patients with chronic heart failure. A total of 40 participants will be randomly assigned into two groups in a single-blinded design. Both groups will undergo a 10-week supervised exercise program. Outcomes will be assessed using VO₂ peak, 6-Minute Walk Test (6MWT), Short Physical Performance Battery (SPPB), and quality of life measures. The study aims to determine the more effective rehabilitation approach for improving clinical outcomes in heart failure patients.

Detailed description

Heart failure is a chronic and progressive condition associated with reduced functional capacity, impaired cardiorespiratory fitness, and decreased lower limb performance, significantly affecting quality of life. Exercise-based cardiac rehabilitation is an established intervention; however, the comparative effectiveness of different exercise modalities, particularly neuromuscular training and resistance training, remains insufficiently explored. This study is a single-blinded randomized controlled trial designed to compare the effects of neuromuscular training and resistance training on functional capacity, cardiorespiratory fitness, and lower limb performance in patients with chronic heart failure. A total of 40 participants meeting the inclusion criteria will be recruited from tertiary care hospitals and cardiac rehabilitation centers. After baseline assessment, participants will be randomly allocated into two groups using a concealed allocation method. Both groups will undergo a supervised 10-week intervention program consisting of 20 sessions (2 sessions per week). Each session will include warm-up, 20 minutes of specific training, 20 minutes of moderate-intensity aerobic exercise, and cool-down. The resistance training group will perform exercises targeting major muscle groups at moderate intensity (50-70% of one-repetition maximum), while the neuromuscular training group will focus on balance, coordination, proprioception, and motor control using structured functional exercises. Primary outcome measures will include cardiorespiratory fitness (VO₂ peak assessed via Chester Step Test), functional capacity (6-Minute Walk Test), and lower limb performance (Short Physical Performance Battery). Secondary outcomes will include resting heart rate, blood pressure, oxygen saturation, perceived exertion (Borg CR-10), and quality of life measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ). Assessments will be conducted at baseline and after completion of the intervention by a blinded assessor to minimize bias. Data will be analyzed using appropriate statistical methods to compare within-group and between-group differences. This study aims to generate evidence on the comparative effectiveness of neuromuscular and resistance training, which may help in optimizing cardiac rehabilitation protocols and improving clinical outcomes in patients with heart failure.

Interventions

BEHAVIORALResistance Training

A supervised resistance training program targeting major muscle groups using resistance bands, machines, and bodyweight exercises. Training intensity will be set at 50-70% of one-repetition maximum and progressed based on patient tolerance. Each session will include warm-up, 20 minutes of resistance exercises, 20 minutes of moderate-intensity aerobic exercise, and cool-down. Sessions will be conducted twice weekly for 10 weeks.

BEHAVIORALNeuromuscular Training

A supervised neuromuscular training program focusing on balance, coordination, proprioception, and postural control. Exercises will include dynamic balance tasks, limb coordination, and training on unstable surfaces. Each session will include warm-up, 20 minutes of neuromuscular exercises, 20 minutes of moderate-intensity aerobic exercise, and cool-down. Sessions will be conducted twice weekly for 10 weeks.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

This is a single-blinded study in which the outcome assessor will be blinded to group allocation to minimize assessment bias. Participants and therapists will not be blinded due to the nature of the interventions.

Intervention model description

Participants will be randomly assigned into two parallel groups: one receiving resistance training and the other receiving neuromuscular training. Both groups will undergo supervised exercise sessions along with standard aerobic training for 10 weeks, and outcomes will be compared between groups.

Eligibility

Sex/Gender
ALL
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Male and female patients aged 40-60 years * Diagnosed with chronic heart failure ≥ 1 year * Heart failure with reduced ejection fraction (HFrEF), EF ≤ 40% * NYHA Class II-III * Low to moderate exercise risk (based on Chester Step Test) * On stable pharmacological treatment for ≥ 6 weeks * Able to understand and follow exercise instructions

Exclusion criteria

* Absolute contraindications to exercise (e.g., recent MI, unstable angina, uncontrolled arrhythmias, severe aortic stenosis, decompensated HF) * Abnormal CPET findings (severe arrhythmias, ischemia, ST depression) * Abnormal blood pressure response during exercise * Exercise-induced angina or thoracic pain * Musculoskeletal, neurological, or cognitive impairments limiting exercise participation

Design outcomes

Primary

MeasureTime frameDescription
Functional CapacityBaseline and after 10 weeks of interventionFunctional capacity will be assessed using the Six-Minute Walk Test (6MWT), which measures the distance a participant can walk on a flat surface in 6 minutes. It is a validated and reliable measure used in cardiac rehabilitation to evaluate exercise tolerance and daily functional ability in patients with heart failure.
Cardiorespiratory Fitness (VO₂ Peak)Baseline and after 10 weeks of interventionCardiorespiratory fitness will be assessed using the Chester Step Test, which estimates VO₂ peak based on heart rate response during graded stepping exercise. VO₂ peak is a key indicator of aerobic capacity and cardiovascular health in patients with heart failure.
Lower Limb PerformanceBaseline and after 10 weeks of interventionLower limb performance will be assessed using the Short Physical Performance Battery (SPPB), which includes balance tests, gait speed, and chair stand tests. It is a validated tool for assessing lower extremity function in clinical populations.

Countries

Pakistan

Contacts

CONTACTMuhammad Iqbal Tariq, Phd*
iqbal.tariq@riphah.edu.pk03338236752
PRINCIPAL_INVESTIGATORArjumand Bano, MSPT

Riphah International University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 10, 2026